The global urology devices market size is expected to be valued at US$ 38.6 billion in 2026 and is projected to reach US$ 58.8 billion, growing at a CAGR of 6.2% between 2026 and 2033. Rising prevalence of urological disorders, including kidney stones, benign prostatic hyperplasia (BPH), urinary incontinence, bladder cancer, and prostate cancer, is a primary factor driving demand for advanced urology devices across hospitals, ambulatory surgical centers, and specialty urology clinics. Market growth is further supported by the increasing global aging population, as age-related urological conditions continue to place a greater burden on healthcare systems.

Continuous advancements in minimally invasive and robotic-assisted urological procedures, high-definition endoscopy, laser lithotripsy systems, and digital urodynamic technologies are expanding treatment options while improving clinical outcomes and patient recovery. Increasing investments in modern healthcare infrastructure, wider adoption of outpatient urological procedures, and favorable reimbursement policies in developed markets are enhancing access to advanced urology care. In addition, growing awareness of early diagnosis, rising healthcare expenditure, and ongoing technological innovations in imaging-guided interventions, flexible endoscopy, and smart catheter technologies are expected to support sustained market growth across both developed and emerging economies.

Drivers

Rising Global Prevalence of Urological Disorders Driving Demand for Advanced Urology Devices

The increasing prevalence of urological disorders, including kidney stone disease, benign prostatic hyperplasia (BPH), urinary incontinence, bladder cancer, prostate cancer, urinary tract infections, and chronic kidney disease, is a major factor driving the growth of the urology devices market. The rising incidence of these conditions is closely associated with the expanding geriatric population, increasing obesity, diabetes, sedentary lifestyles, and changing dietary habits, all of which contribute to higher demand for diagnostic and therapeutic urological procedures. Hospitals, ambulatory surgical centers, and specialty urology clinics are witnessing a growing number of procedures such as cystoscopy, ureteroscopy, laser lithotripsy, prostate surgery, and urodynamic testing, leading to increased adoption of advanced urology devices.

Furthermore, greater awareness regarding early diagnosis, expanding access to specialized healthcare services, rising healthcare expenditure, and continuous improvements in healthcare infrastructure are enabling more patients to receive timely treatment. Government initiatives promoting early disease detection and increasing investments in modern medical technologies are also supporting procedural growth, while the growing preference for minimally invasive interventions continues to strengthen long-term demand for innovative urology devices.

Continuous Advancements in Minimally Invasive and Robotic-Assisted Urology Technologies

Continuous technological innovation is significantly transforming urological diagnosis and treatment by improving procedural precision, clinical outcomes, and patient safety. Manufacturers are introducing advanced flexible and digital endoscopes, high-power laser lithotripsy systems, disposable ureteroscopes, AI-assisted imaging solutions, and robotic-assisted surgical platforms that enable minimally invasive treatment with smaller incisions, reduced blood loss, shorter hospital stays, and faster patient recovery. These advancements have increased physician preference for minimally invasive procedures over conventional open surgeries for the management of kidney stones, prostate disorders, bladder diseases, and urological cancers.

In addition, the growing adoption of robotic-assisted surgery for procedures such as radical prostatectomy and partial nephrectomy is expanding the utilization of sophisticated urology devices worldwide. Continuous investments in research and development, increasing regulatory approvals for next-generation technologies, and integration of advanced visualization and digital navigation systems are further enhancing the efficiency and accuracy of urological procedures.

Restraints - High Cost of Advanced Urology Devices and Procedures

The high acquisition and operational costs associated with advanced urology devices remain a significant challenge for market expansion, particularly across developing and price-sensitive regions. Robotic-assisted surgical platforms, laser lithotripsy equipment, digital endoscopy systems, urodynamic devices, and advanced imaging technologies require substantial capital investment, while maintenance, software upgrades, disposable accessories, and specialized staff training further increase the overall cost of ownership.

Many hospitals and healthcare providers operating under limited budgets continue to rely on conventional equipment due to financial constraints, delaying the adoption of next-generation technologies. In addition, inconsistent reimbursement policies and significant out-of-pocket expenses for patients undergoing advanced minimally invasive procedures reduce treatment accessibility in several regions. These economic barriers limit the widespread implementation of technologically advanced urology devices and continue to moderate market growth despite their proven clinical benefits.

Shortage of Skilled Urologists and Technical Complexity of Advanced Procedures

The growing adoption of sophisticated urology devices is constrained by the limited availability of experienced urologists and trained healthcare professionals capable of performing advanced minimally invasive and robotic-assisted procedures. Modern urology technologies require specialized clinical expertise, extensive training, and continuous skill development to ensure safe and effective operation. Many healthcare facilities, particularly in rural and developing regions, continue to experience shortages of qualified specialists and lack the infrastructure required to support complex urological procedures.

The steep learning curve associated with robotic surgery, digital endoscopy, and advanced laser systems may initially reduce procedural efficiency while increasing training costs for healthcare providers. These workforce limitations, combined with unequal access to specialized healthcare services and advanced surgical infrastructure, continue to slow down the adoption of innovative urology technologies across several regions.

Opportunities - Growing Adoption of Robotic-Assisted Urological Surgery

The rising adoption of robotic-assisted surgery presents a significant growth opportunity for the market as healthcare providers increasingly invest in advanced surgical technologies that improve clinical outcomes and patient satisfaction. Robotic surgical systems offer enhanced visualization, greater instrument precision, improved dexterity, and better ergonomics, enabling surgeons to perform complex procedures such as radical prostatectomy, partial nephrectomy, bladder reconstruction, and pyeloplasty with greater accuracy than conventional techniques.

These systems also reduce blood loss, minimize surgical trauma, shorten hospital stays, and accelerate patient recovery, making them increasingly preferred for minimally invasive urological procedures. Rising investments in robotic surgical infrastructure, growing surgeon training programs, expanding clinical evidence supporting robotic interventions, and increasing patient preference for advanced minimally invasive treatments are expected to drive strong demand for robotic-assisted urology devices throughout the forecast period.

Increasing Demand for Advanced Kidney Stone Management Technologies

The rising global incidence and recurrence of kidney stone disease are creating substantial opportunities for manufacturers of laser lithotripsy systems, flexible ureteroscopes, stone retrieval devices, and related consumables. Healthcare providers are increasingly adopting advanced laser technologies and minimally invasive endoscopic procedures because they provide higher treatment success rates, improved procedural efficiency, reduced complications, and faster patient recovery compared with conventional surgical approaches.

At the same time, growing demand for disposable urology devices is improving infection control, reducing sterilization requirements, and enhancing workflow efficiency in hospitals and ambulatory surgical centers. Continuous technological advancements, expanding outpatient urology services, increasing healthcare investments, and improving access to specialized stone management procedures across emerging economies are expected to generate significant long-term growth opportunities for manufacturers operating in the global urology devices market.

Product Type Insights

Endoscopes are a leading product type segment, accounting for an estimated 31.8% of the urology devices market share in 2026. Their dominance is driven by the widespread use of cystoscopes, ureteroscopes, nephroscopes, and resectoscopes for the diagnosis and minimally invasive treatment of a broad range of urological disorders, including kidney stones, bladder cancer, benign prostatic hyperplasia (BPH), urethral strictures, and urinary tract abnormalities. Endoscopic procedures have become the preferred standard of care due to their ability to provide direct visualization of the urinary tract while reducing surgical trauma, shortening hospital stays, and enabling faster patient recovery compared with open surgical procedures.

Continuous technological advancements, including high-definition digital imaging, flexible endoscopes, disposable ureteroscopes, and improved visualization systems, have further enhanced procedural accuracy and physician confidence. Moreover, the growing preference for minimally invasive surgery, increasing procedural volumes, and continuous product innovations introduced by leading manufacturers continue to strengthen the segment’s leading position in the market.

Laser & lithotripsy devices is the fastest-growing segment, driven by the rising prevalence of kidney stones and increasing preference for minimally invasive stone-management procedures that offer greater precision, shorter recovery times, and fewer complications. Technological advancements in high-power holmium and thulium fiber lasers are further improving stone fragmentation efficiency and expanding their use across kidney stones, urinary tract stones, and other urological procedures.

Application Insights

Kidney stone disease (Urolithiasis) is the leading application, accounting for nearly 35.6% of the market share in 2026. The segment's leadership is primarily driven by the rising global incidence of kidney stone disease. Growing patient awareness and the increasing availability of minimally invasive treatment options, such as ureteroscopy, laser lithotripsy, and percutaneous nephrolithotomy, have significantly increased procedural volumes across healthcare facilities.

Continuous improvements in laser technologies, flexible endoscopy, and stone retrieval devices have enhanced treatment success rates while minimizing complications and recovery time. Furthermore, the high recurrence rate of kidney stones and increasing investments in advanced stone management technologies continue to generate sustained demand for urology devices, reinforcing the segment's dominant position throughout the forecast period.

End-User Insights

Hospitals are projected to lead the urology devices market by holding the largest share of 56.9% in 2026. Their leadership is supported by the availability of advanced surgical infrastructure, comprehensive diagnostic capabilities, and highly skilled multidisciplinary teams capable of managing both routine and complex urological conditions. Most procedures involving endoscopy, laser lithotripsy, robotic-assisted surgery, prostate treatment, and bladder cancer management are performed in hospitals due to the presence of sophisticated imaging systems, operating rooms, intensive care units, and emergency care facilities.

Hospitals also serve as major referral centers for patients requiring specialized urological interventions and postoperative care. In addition, increasing investments in hospital modernization, rising adoption of minimally invasive surgical technologies, growing healthcare expenditure, and expanding access to advanced urology services continue to strengthen hospitals' dominant position in the market.

North America Urology Devices Market Trends and Insights

North America is expected to dominate the global urology devices market by holding about 39.4% share in 2026. The region’s dominance is attributed to its advanced healthcare infrastructure, high adoption of minimally invasive urological procedures, favorable reimbursement policies, and widespread availability of specialized urology centers. The increasing prevalence of kidney stone disease, benign prostatic hyperplasia (BPH), urinary incontinence, bladder cancer, and prostate cancer continues to drive demand for advanced diagnostic and therapeutic urology devices.

Continuous technological advancements in robotic-assisted surgery, laser lithotripsy systems, digital endoscopy, and AI-enabled imaging solutions have further strengthened market growth. The presence of leading medical device manufacturers, strong clinical research activities, and rapid regulatory approvals for innovative technologies support the commercialization of next-generation urology devices. In addition, rising healthcare expenditure, growing awareness of early diagnosis, and increasing investments in hospital modernization continue to reinforce North America's dominant position in the global market.

U.S. Urology Devices Market Trends and Insights

The U.S. accounts for around 85.1% of the North American urology devices market, supported by an extensive network of hospitals and specialty urology centers, high procedural volumes, strong reimbursement coverage, and rapid adoption of advanced medical technologies. Increasing utilization of robotic-assisted surgery, laser lithotripsy, flexible ureteroscopy, and digital cystoscopy continues to improve clinical outcomes while driving demand for innovative urology devices.

Continuous investments in research and development, favorable regulatory approvals, and the presence of major global manufacturers further strengthen the U.S. market. Additionally, the growing elderly population and increasing prevalence of chronic urological disorders are expected to sustain long-term market expansion.

Canada Urology Devices Market Trends and Insights

Canada represents the fastest-growing market within North America, driven by increasing healthcare investments, an aging population, and the rising prevalence of kidney stones, urinary incontinence, and prostate disorders. Hospitals across the country continue expanding access to minimally invasive urological procedures through investments in advanced laser systems, digital endoscopy platforms, and robotic-assisted surgical technologies. Government initiatives promoting early diagnosis and improved access to specialized healthcare services, along with collaborations between academic institutions and medical device manufacturers, continue to encourage the adoption of innovative urology devices throughout the country.

Europe Urology Devices Market Trends and Insights

Europe is projected to hold nearly 28.1% share of the urology devices market in 2026, supported by well-established healthcare systems, favorable reimbursement frameworks, and widespread adoption of minimally invasive urological procedures. Increasing prevalence of age-related urological disorders, combined with continuous investments in hospital modernization and digital healthcare infrastructure, is driving demand for advanced urology devices across the region.

Hospitals and specialty urology clinics in the region are increasingly adopting robotic-assisted surgery, laser lithotripsy systems, and high-definition endoscopy technologies to improve procedural efficiency and patient outcomes. Strong clinical research capabilities, the presence of leading medical technology companies, and growing physician expertise continue to reinforce Europe's position as a significant market for urology devices.

Germany Urology Devices Market Trends and Insights

Germany accounts for about 24.1% of the European urology devices market revenue. The country benefits from advanced hospital infrastructure, highly skilled urologists, extensive adoption of minimally invasive surgical technologies, and strong government support for healthcare innovation. Continuous investments in robotic-assisted surgery, laser-based stone management, and digital endoscopy systems, together with active participation in clinical research, continue to strengthen demand for advanced urology devices across hospitals and specialty clinics.

U.K. Urology Devices Market Trends and Insights

The U.K. is anticipated to hold a substantial share of the European market in 2026. Rising demand for minimally invasive treatment, increasing prevalence of prostate and bladder disorders, and continued investments through the National Health Service (NHS) are supporting market growth. Healthcare providers are expanding access to advanced diagnostic imaging, robotic-assisted surgery, and laser lithotripsy technologies to improve treatment quality and patient outcomes. Ongoing modernization of healthcare infrastructure and growing emphasis on early diagnosis continue to drive the adoption of innovative urology devices across the country.

Asia Pacific Urology Devices Market Trends and Insights

Asia Pacific represents the fastest-growing market, driven by rapid urbanization, increasing healthcare expenditure, improving access to specialized urology care, and the growing burden of kidney stones, prostate disorders, and urinary tract diseases. Governments continue investing in healthcare infrastructure while private hospital networks expand advanced urology departments and minimally invasive surgical capabilities.

Growing awareness regarding early diagnosis, increasing physician expertise, and rising adoption of robotic-assisted surgery, laser lithotripsy, and digital endoscopy technologies continue to support strong market expansion. Furthermore, large aging populations, improving medical insurance coverage, and rising healthcare investments are expected to sustain long-term market growth.

China Urology Devices Market Trends and Insights

China accounts for around 40.2% of the Asia Pacific urology devices market revenue,driven by the country's large patient population, expanding healthcare infrastructure, increasing prevalence of kidney stone disease and prostate disorders, and continuous healthcare reforms. Domestic manufacturers continue to strengthen production capabilities while introducing technologically advanced and cost-effective urology devices. Increasing investments in tertiary hospitals, greater adoption of minimally invasive surgical techniques, and supportive government policies promoting medical device innovation are expected to accelerate market expansion over the coming years.

India Urology Devices Market Trends and Insights

India is projected to hold a significant share of the Asia Pacific urology devices market in 2026. Rising healthcare expenditure, increasing prevalence of urological disorders, expanding multispecialty hospitals, and improving access to advanced diagnostic and therapeutic procedures continue to drive market growth. Government healthcare initiatives, rapid expansion of private healthcare providers, and increasing availability of affordable urology devices are supporting greater adoption of minimally invasive procedures across both urban and semi-urban regions. Furthermore, growing physician expertise, rising awareness regarding early disease diagnosis, and continued investments in advanced surgical technologies are expected to position India among the fastest-growing markets within Asia Pacific.

The global urology devices market is moderately consolidated, with Boston Scientific Corporation, Coloplast A/S, Becton, Dickinson and Company, Teleflex Incorporated, and Olympus Corporation leading the competitive landscape through broad product portfolios, strong global distribution networks, and continuous product innovation. These companies focus on expanding their presence through advanced endoscopy systems, urinary catheters, laser lithotripsy devices, and minimally invasive surgical technologies. Meanwhile, B. Braun Melsungen AG, Intuitive Surgical, Inc., Medtronic plc, KARL STORZ SE & Co. KG, Cook Medical LLC, and other regional players continue to strengthen market competition through product launches, strategic collaborations, and geographic expansion.

Key Market Developments

• In March 2026, Cook Medical commercially launched the Syfonix Suction Ureteral Access Sheath and the 7.5 Fr Ascend Single-Use Flexible Ureteroscope in the U.S. and Canada, expanding its portfolio of minimally invasive urology devices for stone management procedures.
• In December 2025, Medtronic received U.S. FDA clearance for its Hugo robotic-assisted surgery (RAS) system for urologic surgical procedures, expanding access to minimally invasive robotic surgery for hospitals and surgeons across the U.S.